ARPA-H SBIR/STTR
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
ARPA-H operates its own Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) program, publishing topic-specific calls annually aligned to current Mission Office priorities. Award sizes follow SBA statutory caps: Phase I awards are capped at $323,090 over 6 to 12 months; Phase II awards are capped at $2,153,927 over one to three years. The program deploys an estimat…
Health R&D topics published in ARPA-H's annual SBIR/STTR topic list. Topics are aligned to current ARPA-H Mission Office priorities and may include drug platforms, devices, digital health, biomanufacturing, and clinical infrastructure.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from ARPA-H
All grants from this funder →ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
ARPA-H Program ISOs (topic-specific)
🇺🇸ARPA-H · United States
Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
BioStabilization Systems (BoSS)
🇺🇸ARPA-H · United States
Funds teams engineering room-temperature storage for biologic drugs and cell therapies.
Intelligent Generator of Research (IGoR)
🇺🇸ARPA-H · United States
Funds teams building an AI-orchestrated ecosystem to speed up biomedical research.
One Comprehensive Universal Radiotherapy for Everyone (1-CURE)
🇺🇸ARPA-H · United States
Funds research teams developing a single low-cost radiotherapy treatment for all cancers.
Similar grants
Browse the directory →
Defense Health Agency SBIR Phase II
🇺🇸DHA · United States
Supports United States defense health teams maturing validated medical technologies toward practical military use.
DTRA C-WMD Basic Research BAA
🇺🇸DTRA · United States
Supports fundamental and early-stage scientific research that protects against chemical, biological, radiological, and nuclear risks.
Defense Health Agency SBIR Phase I
🇺🇸DHA · United States
Funds United States defense medical innovators at feasibility stage for life-changing military health technologies.
NIDA SBIR/STTR
🇺🇸NIDA · United States
Supports United States. small businesses advancing drug abuse intervention and treatment technologies.
Complement-ARIE — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports development of human-based new approach methodologies replacing animal models in relevant research.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.